Ant Uzay

758 total citations · 1 hit paper
21 papers, 433 citations indexed

About

Ant Uzay is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Ant Uzay has authored 21 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Pathology and Forensic Medicine and 7 papers in Oncology. Recurrent topics in Ant Uzay's work include Chronic Myeloid Leukemia Treatments (5 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Ant Uzay is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Ant Uzay collaborates with scholars based in Türkiye, Japan and Switzerland. Ant Uzay's co-authors include Mahmut Bayık, Işık Kaygusuz, Franco Locatelli, Maurizio Musso, Norbert Hollaender, Ronjon Chakraverty, Peter Langmuir, Takanori Teshima, Nicola Polverelli and Jan Moritz Middeke and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ant Uzay

18 papers receiving 429 citations

Hit Papers

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-v... 2021 2026 2022 2024 2021 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
    2021 271 citations Robert Zeiser, Nicola Polverelli et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ant Uzay Türkiye 8 254 126 96 95 92 21 433
Anna Sandstedt Sweden 10 284 1.1× 114 0.9× 136 1.4× 197 2.1× 150 1.6× 17 486
David Pohlreich Czechia 12 291 1.1× 182 1.4× 219 2.3× 182 1.9× 61 0.7× 21 540
Kristin A. Shimano United States 14 317 1.2× 81 0.6× 169 1.8× 53 0.6× 94 1.0× 36 586
Michelle Donato United States 9 337 1.3× 201 1.6× 111 1.2× 176 1.9× 93 1.0× 12 534
Joyce Murata‐Collins United States 12 175 0.7× 99 0.8× 60 0.6× 135 1.4× 70 0.8× 31 488
Jacopo Olivieri Italy 11 134 0.5× 74 0.6× 56 0.6× 82 0.9× 81 0.9× 24 374
Francesca Lunghi Italy 8 109 0.4× 164 1.3× 148 1.5× 85 0.9× 51 0.6× 19 378
Luisa Tavecchia Italy 10 148 0.6× 85 0.7× 110 1.1× 111 1.2× 124 1.3× 12 390
Pierre Hirsch France 15 294 1.2× 143 1.1× 53 0.6× 69 0.7× 158 1.7× 39 568
Zhengming Jin China 15 325 1.3× 270 2.1× 127 1.3× 102 1.1× 72 0.8× 98 660

Countries citing papers authored by Ant Uzay

Since Specialization
Citations

This map shows the geographic impact of Ant Uzay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ant Uzay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ant Uzay more than expected).

Fields of papers citing papers by Ant Uzay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ant Uzay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ant Uzay. The network helps show where Ant Uzay may publish in the future.

Co-authorship network of co-authors of Ant Uzay

This figure shows the co-authorship network connecting the top 25 collaborators of Ant Uzay. A scholar is included among the top collaborators of Ant Uzay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ant Uzay. Ant Uzay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Uzay, Ant, et al.. (2022). Daily low dose intravesical cidofovir for the treatment of BK virus associated hemorrhagic cystitis after allogeneic stem cell transplantation. Journal of Infection and Chemotherapy. 29(1). 67–71. 4 indexed citations
5.
Dal, Mehmet Sinan, Ant Uzay, Olga Meltem Akay, et al.. (2022). Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey. Annals of Hematology. 102(1). 133–140. 8 indexed citations
6.
7.
Ferhanoğlu, Burhan, Zafer Gülbaş, Ant Uzay, et al.. (2022). Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data. Blood. 140(Supplement 1). 6704–6705. 7 indexed citations
8.
Zeiser, Robert, Nicola Polverelli, Ron Ram, et al.. (2021). Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease. New England Journal of Medicine. 385(3). 228–238. 271 indexed citations breakdown →
9.
İlhan, Osman, Güldane Cengiz Seval, Ant Uzay, et al.. (2020). Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease. Biology of Blood and Marrow Transplantation. 26(3). S191–S191.
10.
Aydıngöz, İkbal Esen, et al.. (2020). Fusariosis manifesting as targetoid purpuric cutaneous lesions in immunocompromised patients. Journal of the European Academy of Dermatology and Venereology. 34(11). e734–e736. 1 indexed citations
11.
Uzay, Ant, et al.. (2018). Successful Preoperative Treatment with Plasmapheresis of Patients with Hyperthyroidism. Endocrinology research and practice.. 22(2). 113–116. 3 indexed citations
12.
13.
Bek, Sibel Gökçay, et al.. (2018). Rh (D) alloimmunization treated by double filtration plasmapheresis. Transfusion and Apheresis Science. 58(1). 83–86. 4 indexed citations
14.
Uzay, Ant, et al.. (2015). Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literature. International Journal of Hematology. 102(3). 383–387. 9 indexed citations
15.
Uzay, Ant, et al.. (2012). The Prognostic Value of CD49d Expression in Turkish Patients with Chronic Lymphocytic Leukemia. Turkish Journal of Hematology. 29(4). 354–360. 4 indexed citations
16.
Uzay, Ant, Tayfur Toptaş, Işık Kaygusuz, et al.. (2012). The prognostic value of CD49d expression in Turkish patients with chronic lymphocytic leukemia. SHILAP Revista de lepidopterología. 2 indexed citations
17.
Kaygusuz, Işık, et al.. (2011). Bortezomib in patients with renal impairment. Hematology. 16(4). 200–208. 8 indexed citations
18.
Öztürk, Mehmet Akif, Faysal Dane, Işık Kaygusuz, et al.. (2010). Synchronous renal cell carcinoma and multiple myeloma: report of two cases and review of the literature.. PubMed. 14(3). 511–4. 10 indexed citations
19.
Kaygusuz, Işık, et al.. (2009). Bortezomib: a new therapeutic option for POEMS syndrome. European Journal Of Haematology. 84(2). 175–177. 39 indexed citations
20.
Adıgüzel, Cafer, Süheyla Bozkurt, Işık Kaygusuz, et al.. (2009). Human herpes virus 8‐unrelated primary effusion lymphoma‐like lymphoma: report of a rare case and review of the literature. Apmis. 117(3). 222–229. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Sandstedt Breakdown of academic impact, for papers by David Pohlreich Breakdown of academic impact, for papers by Kristin A. Shimano Breakdown of academic impact, for papers by Michelle Donato Breakdown of academic impact, for papers by Joyce Murata‐Collins Breakdown of academic impact, for papers by Jacopo Olivieri Breakdown of academic impact, for papers by Francesca Lunghi Breakdown of academic impact, for papers by Luisa Tavecchia Breakdown of academic impact, for papers by Pierre Hirsch Breakdown of academic impact, for papers by Zhengming Jin
Rankless by CCL
2026